The publication of a large number of randomised controlled trials in heart failure patients over the last 25 years has allowed the development of several excellent evidence-based guidelines.1–3 Revised SIGN guidelines for heart failure are due for publication this year.3 The major challenge facing us now is the implementation of these evidence-based therapies and the allocation of resources to allow the development and assessment of emerging technologies to ensure that patients receive the treatments they need.
Get full access to this article
View all access options for this article.
References
1.
RemmeWJTask force for the diagnosis and treatment of chronic heart failureSwedberg K.European Society ofCardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22:1527–60.
2.
National Institute for Clinical Excellence. Chronic Heart Failure. (Clinical Guideline No.5).
3.
http://www.sign.ac.uk/
4.
KhuntiKSquireI Accuracy of a 12-lead ECG in screening patients with suspected HF for OAE: a systematic review and meta-analysis EJHF 2004;6:571–6.
5.
CowieMR.BNP: soon to become a routine measure in the care of patients with heart failure. Heart 2000;83:617–8.
6.
ClelandJGACohen-SolalAguilarJC IMPROVEMENT of Heart Failure Programme Committees and Investigators. Improvement programme in evaluation and management; Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631–9.
7.
FuatAAPSHunginMurphyJJ.The diagnosis and management of heart failure across primary-secondary care: a qualitative study of specialists’ views and attitudes. Br J Cardiol 2005;12:233–8.
8.
FuatAAPSHunginMurphyJJ.Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003;326:196–200.
9.
RoccaforteRCDemersFBaldassarreKKTeoYusufS. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A metaanalysis. Eur J Heart Fail 2005;7:1133–44.
10.
BristowMRLASaxonBoehmerJ Comparison of medical therapy, pacing and Defibrillation in heart failure (COMPANION) Investigators. Cardiac-resynchronisation therapy with or without an implantable defibrillator in advanced heart failure. N Eng J Med 2004;350:2140–50.
11.
ClelandJGJCDaubertErdmannE Cardiac resynchronisation heart failure (CARE-HF) study investigators. The effect of cardiac resynchronisation on mortality and morbidity in heart failure. N Eng J Med 2005;352:1539–49.
12.
MurraySAKBoydKendallM Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ 2002;235:929–34.
